Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
17.10.2023 - GARDEN CITY, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) - Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric . Seite 1
GARDEN CITY, N.Y., Oct. 16, 2023 Beyond Air, Inc. , a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide to.
18.09.2023 - New data demonstrates a therapeutic effect for at least 10 days after a single subcutaneously (SC) injection of an extended-release selective neuronal nitric oxide synthase (nNOS) inhibitor The slow-release formulation led to reversal of . Seite 1
Beyond Air, Inc (XAIR) Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.